New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)

NAActive, not recruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

April 29, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

April 30, 2026

Conditions
Major Depressive Disorder
Interventions
DEVICE

Brainsway Deep TMS System

The BrainsWay Deep TMS device is intended for the treatment of depressive episodes in patients suffering from Major Depressive Disorder (MDD). The device technology is based on the application of deep brain TMS by means of repetitive pulse trains at a determined frequency.

Trial Locations (9)

11249

Fermata Health, Brooklyn

19001

Complete Mind Care of PA, Abington

25303

PsyCare, South Charleston

33401

DTMS Center LLC, Palm Beach

35401

Novus Neurology, Tuscaloosa

70350

Be'er Ya'aqov-Ness Ziona Mental Health Center, Be’er Ya‘aqov

92373

Inland Psychiatric Medical Group, Inc., Redlands

98105

ClearPath Psychiatry, Seattle

500032

Asha Neuromodulation Clinic, Hyderabad

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Brainsway

INDUSTRY